Obesity and cardiovascular risk factors in rheumatoid arthritis-Reference-Cited by-同舟云学术

Obesity and cardiovascular risk factors in rheumatoid arthritis

Published:2006-04-21 Issue:6 Volume:45 Page:782-782
ISSN:1462-0332
Container-title:Rheumatology
language:en
Short-container-title:

Author:

Armstrong D. J.,McCausland E. M.,Quinn A. D.,Wright G. D.

Publisher

Oxford University Press (OUP)

Subject

Pharmacology (medical),Rheumatology

Link

http://academic.oup.com/rheumatology/article-pdf/45/6/782/5048692/kel124.pdf

Reference3 articles.

1. Hall FC, Dalbeth N. Disease modification and cardiovascular risk reduction: two sides of the same coin? Rheumatology2005;44: 1473–82.

2. Liu S, Manson JAE. What is the optimal weight for cardiovascular health? Br Med J2001;322:631–2.

3. National Institute for Clinical Excellence. Technology Appraisal Guidance – No. 22 Guidance on the Use of Orlistat for the Treatment of Obesity in Adults. March2001.

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Obesity in rheumatoid arthritis: impact on response to biologic therapies;Exploration of Musculoskeletal Diseases;2024-06-12

2. Impact of Obesity on Response Rate for Biological Agents in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis of Cohort Studies;J BIOL REG HOMEOS AG;2024

3. Body mass index does not affect response of rituximab in patients with rheumatoid arthritis: results from the TURKBİO registry;Turkish Journal of Medical Sciences;2023-10-26

4. Non-coding RNA network associated with obesity and rheumatoid arthritis;Immunobiology;2022-11

5. Comparison of Psoriatic Arthritis and Rheumatoid Arthritis Patients across Body Mass Index Categories in Switzerland;Journal of Clinical Medicine;2021-07-20